To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Dexmedetomidine vs Bupivacaine for ESPB in Lumbosacral Spine Surgery Pain Control

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
June 2025

Dexmedetomidine vs Bupivacaine for ESPB in Lumbosacral Spine Surgery Pain Control

Vol: 307| Issue: 6| Number:84| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Comparative Study Between Dexmedetomidine with Bupivacaine and Bupivacaine Alone in Erector Spinae Plane Block for Postoperative Pain Control of Posterior Lumbosacral Spine Fixation Surgeries: A Randomized Controlled Trial.

Drug Des Devel Ther . 2024 Feb 7:18:351-363.

Contributing Authors:
SHA Abu El Hassan EA Wahsh AM Mousa ARN Ibrahim EL Mohammed

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Ninety patients undergoing posterior lumbosacral spine fixation were randomized to receive either dexmedetomidine plus bupivacaine (n=30), bupivacaine alone (n=30), or saline (n=30) for bilateral ultrasound-guided erector spinae plane block (ESPB). Pain management included IV paracetamol and patient-controlled morphine analgesia. Outcomes included active and passive pain scores (VAS), opioid consu...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue